From surgical staplers to birthing simulator updates, 2014 brought many new innovations for obstetrics and gynecology.
New technology has the potential to make surgical procedures more efficient and effective, reduce errors, and improve patient care and outcomes. It'll take some time before we know which innovations will be adopted as standard practice, but here are a few new items that 2014 brought.
Echelon Flex GST Stapler
This new stapler, by Ethicon, has a gripping surface that eliminates slippage when stapling tissue that has different dimensions of thickness. The stapling procedure time is reduced because gynecologists don’t have to stop and reload the stapler. The stapler gives consistently good firing results due to the improved grasping technology.
The Extracorporeal C-Incision Tissue Extraction
The Extracorporeal C-Incision Tissue Extraction (ExCITE) technique provides a new alternative for extracting contained tissue when performing gynecological surgery. Myomectomy and hysterectomy are prime examples of procedures that can use ExCITE to extract tissue without using power morcellation. This extraction device uses the Anchor Medical containment bag and the Applied Medical self-retaining retractor. This device standardizes the approach to safe tissue extraction, but whether it will catch on is yet to be determined.
Birthing Simulators
The Noelle S2200 birthing simulator, called "Victoria," is a life-sized doll that can go into "labor" and "give birth." It has an 8-hour rechargeable battery, which helps students and trainees stay engaged and in-the-moment during extended labor scenarios. Physicians can experiment with various birthing experiments, which can help reduce errors and improve patient care.
Antiretroviral "Tampon"
An antiretroviral pseudo-tampon, currently being studied and not ready for use, has the potential to protect women from HIV transmission when inserted into the vagina at least 6 minutes before sexual intercourse. The tampon is made of water-soluble nano fibers that contain an antiretroviral agent that coat and protect the vagina when the dissolved. Intercourse further distributes the dosage throughout the vagina. The tampon administration is also being considered for contraceptive use. Although this product may not hit the market for another 10 years, it is given serious consideration because it far exceeds the messiness of gels and the long-dissolve time of the films.
Information Credit: http://health.usnews.com/doctors/gilbert-webb-373659.
Tocolysis use after PPROM not linked to neurodevelopmental outcomes
May 29th 2024A recent study investigated the effects of antenatal tocolysis on neurodevelopmental outcomes among children aged 5.5 years following preterm prelabor rupture of membranes, revealing no significant differences in outcomes.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Study finds youth with developmental disabilities less likely to access reproductive health care
May 22nd 2024A recent study reveals that adolescents with autism and other developmental disabilities have fewer visits to obstetrician-gynecologists and lower hormonal contraceptive use compared to their typically developing peers, highlighting a need for improved reproductive health services.
Read More
LNG-IUS vs. radiofrequency EA for HMB: Similar long-term reintervention risks reported
May 22nd 2024A recent study reveals similar overall reintervention risks between a 52-mg levonorgestrel-releasing intrauterine system and radiofrequency endometrial ablation for treating heavy menstrual bleeding.
Read More